Newcastle University
Toggle Main Menu
Toggle Search
Home
Browse
Latest
Policies
About
Home
Browse
Latest
Policies
About
ePrints
Browse by author
Browsing publications by
Dr Philip Hampton.
Newcastle Authors
Title
Year
Full text
Dr Philip Hampton
Professor Nick Reynolds
Randomized Trial Replication Using Observational Data for Comparative Effectiveness of Secukinumab and Ustekinumab in Psoriasis: A Study from the British Association of Dermatologists Biologics and Immunomodulators Register
2021
Dr Anna Dubois
Dr Simon Meggitt
Dr Philip Hampton
Description of a disease activity proforma for documentation of hidradenitis suppurativa severity and distribution, and suggestions for use as a patient-reported outcome measure
2020
Dr Philip Hampton
New brodalumab psoriasis outcome data suggests that intermittent treatment is as effective as continuous dosing. Is it time to re-evaluate our treatment regimens?
2020
Dr Hudaa Gopee
Dr Thomas Oliphant
Dr Philip Hampton
Toxic epidermal necrolysis occurring with immune checkpoint inhibitors
2020
Dr Philip Hampton
Dan Richardson
Dr Kyle Montague
Professor Patrick Olivier
Usability testing of MySkinSelfie: a mobile phone application for skin selfâmonitoring
2020
Dr Philip Hampton
A standardization approach to compare treatment safety and effectiveness outcomes between clinical trials and real-world populations in psoriasis
2019
Dr Philip Hampton
Comparison of drug discontinuation, effectiveness, and safety between clinical trial eligible and ineligible patients in BADBIR
2018
Dr Philip Hampton
British Association of Dermatologistsâ guidelines for the management of pemphigus vulgaris 2017
2017
Dr Philip Hampton
Despite numerous recent advances in dermatological therapy, the need for inpatient dermatology care remains considerable
2017
Dr Philip Hampton
Treatment patterns and outcomes among adults admitted to hospital in the U.K. due to plaque or erythrodermic psoriasis
2017
Dr Clifford Lawrence
Dr Catherine Blasdale
Dr Philip Hampton
Following up patients with cutaneous squamous cell carcinoma: 5-year data from a tertiary university centre
2016
Dr Colin Muirhead
Professor Dorothy Newbury-Birch
Professor Eileen Kaner
Dr Eilish Gilvarry
Professor Vera Araujo-Soares
et al.
Examining the prevalence of Alcohol Use Disorders (AUD) in patients with skin disease, a cross-sectional study
2015
Dr Philip Hampton
Professor Nick Reynolds
Predictors of response to increasing the dose of etanercept: results of an audit
2013
Dr Philip Hampton
Dr Ralph Jans
Dr Ross Flockhart
Graeme Parker
Professor Nick Reynolds
et al.
Lithium regulates keratinocyte proliferation via glycogen synthase kinase 3 and NFAT2 (nuclear factor of activated T cells 2)
2012